PCVXVaxcyte

Median target
$113
calls from the last 12 months
Implied return
+87.2%
median target vs. price
Coverage
7 analysts · 7 calls
updated in the last 12 months
Consensus
7/0/0+7 net
Buy / Hold / Sell

Which analysts are behind PCVX's consensus?

See every current rating, price target and the analysts' track records for Vaxcyte — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 7 analysts with calls on PCVX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

PCVX elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-09InsidersWassil JimEVP, Chief Scientific OfInsider sale1.3K sh @ $59.52$79K
2026-09-04InsidersWassil JimEVP, Chief Scientific OfInsider sale1.4K sh @ $61.16$84K
2026-09-01InsidersWassil JimCHIEF OPERATING OFFICERInsider sale1.5K sh @ $60.89$94K
2026-09-01InsidersWassil JimCHIEF OPERATING OFFICERInsider sale924 sh @ $60.95$56K
2026-09-01InsidersWassil JimCHIEF OPERATING OFFICERInsider sale713 sh @ $61.48$44K
2026-09-01InsidersWassil JimCHIEF OPERATING OFFICERInsider sale303 sh @ $61.42$19K
2026-08-05InsidersDhaliwal Harpreet S.Chief Technical Ops OffiInsider sale17.0K sh @ $55.00 · planned trade$935K
2026-08-03InsidersGuggenhime AndrewPRESIDENT AND CFOInsider sale7.0K sh @ $53.76 · planned trade$374K
2026-08-03InsidersGuggenhime AndrewPRESIDENT AND CFOInsider sale3.0K sh @ $54.18 · planned trade$165K
2026-08-03InsidersWassil JimCHIEF OPERATING OFFICERInsider sale1.4K sh @ $54.09 · planned trade$75K

More: congressional trades on PCVX · insider activity · executive branch · trending